mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.095 |
0.006 |
mRNA |
HG-6-64-1 |
GDSC1000 |
pan-cancer |
AAC |
-0.09 |
0.007 |
mRNA |
SN-38 |
CTRPv2 |
pan-cancer |
AAC |
0.097 |
0.007 |
mRNA |
BRD9876:MK-1775 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.31 |
0.007 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.095 |
0.007 |
mRNA |
TAE684 |
GDSC1000 |
pan-cancer |
AAC |
0.14 |
0.008 |
mRNA |
tamatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.096 |
0.008 |
mRNA |
Oxaliplatin |
CTRPv2 |
pan-cancer |
AAC |
0.085 |
0.008 |
mRNA |
thalidomide |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.008 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.09 |
0.008 |